a public good project by the
Synthesis
Company
of California

© 2026

Michael S. Middleton | doi.page

0 works0 citations0 h-index

Michael S. Middleton

University of Central Florida(US)University of California San Diego(US)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Advanced MRI Techniques and Applications, Liver Disease and Transplantation, Hepatocellular Carcinoma Treatment and Prognosis, MRI in cancer diagnosis

Most-Cited Works

→ Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials(2013)537 cited
→ Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis(2013)517 cited
→ In vivo characterization of the liver fat 1H MR spectrum(2010)506 cited
→ SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease(2010)475 cited
→ Heritability of Nonalcoholic Fatty Liver Disease(2009)462 cited
→ Relaxation effects in the quantification of fat using gradient echo imaging(2008)387 cited

→ GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease(2018)

331 cited

→ Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease(2014)329 cited

→ Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial(2020)312 cited

→ Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis(2017)309 cited